Potent trophic effects of aluminum on bone have recently been identified in the investigator's laboratory. In this regard, aluminum substantially increases bone density and volume in normal beagles due to an uncoupling of bone remodeling and de novo bone histogenesis within the marrow cavity. These pharmacologic skeletal effects are unprecedented and may provide a means whereby new three-dimensional trabecular structures can be generated. The long-term objective of this proposal is to understand the mechanism(s) of this unique osteoinductive action. In pursuit of this goal, the effect of aluminum to stimulate bone formation will be further characterized in vivo and the potential to induce mitogenesis in cell culture systems will be explored.
The specific aims of the animal studies are to confirm the time course of aluminum-induced osteogenesis in trabecular bone and to examine the effects of aluminum on cortical bone; to determine if the resultant woven bone remodels, persists after the cessation of aluminum treatment, and imparts structural integrity to bone; and to identify whether this agent can restore bone in osteopenic models. The in vitro studies will: (1) determine if this osteoinductive action is indirectly mediated through the release of paracrine factors from monocytes; and (2) test for potential direct actions of aluminum, explore the interrelationships between aluminum and specific endogenous growth factors and/or exogenous mitogen, and determine the influence of cell differentiation on aluminum action using cell culture systems of osteoblasts and mesenchymal precursors. Information obtained from these studies will likely lead to a better understanding of a novel agent(s) with osteogenic potential and may be useful in designing effective therapy for currently refractory osteopenic disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR037308-06
Application #
3158026
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1986-08-01
Project End
1995-03-31
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Pi, Min; Kapoor, Karan; Ye, Ruisong et al. (2018) GPCR6A Is a Molecular Target for the Natural Products Gallate and EGCG in Green Tea. Mol Nutr Food Res 62:e1700770
Xiao, Zhousheng; Baudry, Jerome; Cao, Li et al. (2018) Polycystin-1 interacts with TAZ to stimulate osteoblastogenesis and inhibit adipogenesis. J Clin Invest 128:157-174
Ye, Ruisong; Pi, Min; Cox, John V et al. (2017) CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model. J Exp Clin Cancer Res 36:90
Pi, Min; Kapoor, Karan; Ye, Ruisong et al. (2016) Evidence for Osteocalcin Binding and Activation of GPRC6A in ?-Cells. Endocrinology 157:1866-80
Pi, Min; Kapoor, Karan; Wu, Yunpeng et al. (2015) Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral Tissues. Mol Endocrinol 29:1759-73
Pi, Min; Quarles, L Darryl (2012) GPRC6A regulates prostate cancer progression. Prostate 72:399-409
Pi, Min; Quarles, L Darryl (2012) Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks. Endocrinology 153:2062-9
Dreaden, Erik C; Gryder, Berkley E; Austin, Lauren A et al. (2012) Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells. Bioconjug Chem 23:1507-12
Pi, Min; Wu, Yunpeng; Lenchik, Nataliya I et al. (2012) GPRC6A mediates the effects of L-arginine on insulin secretion in mouse pancreatic islets. Endocrinology 153:4608-15
Pi, Min; Wu, Yunpeng; Quarles, L Darryl (2011) GPRC6A mediates responses to osteocalcin in ?-cells in vitro and pancreas in vivo. J Bone Miner Res 26:1680-3

Showing the most recent 10 out of 57 publications